Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Steroid Precursor Legislative Action Gains Momentum

This article was originally published in The Tan Sheet

Executive Summary

"Pro-steroid" and "precursor steroid" products' proliferation in the dietary supplement market "raise[s] questions about whether additional federal action should be taken," according to the House Energy & Commerce Committee

You may also be interested in...



Hill expands ephedra investigation

Former Yellow Jackets manufacturer NVE Pharmaceuticals is latest firm to receive House Energy & Commerce Committee letter as part of its ongoing ephedra investigation. Correspondence, sent April 21, asks NVE President Robert Occhifinto to disclose information on its marketing practices and AEs related to sale of Yellow Jackets. Committee also recently expanded its inquiry to include PediaLean children's weight-loss supplement (1"The Tan Sheet" April 14, 2003, p. 4). Yellow Jackets and NVE were the subject of an FDA investigation and concurrent Senate subcommittee hearing in October 2002 (2"The Tan Sheet" Oct. 14, 2002, p. 6). Firm has until May 5 to respond...

Hill expands ephedra investigation

Former Yellow Jackets manufacturer NVE Pharmaceuticals is latest firm to receive House Energy & Commerce Committee letter as part of its ongoing ephedra investigation. Correspondence, sent April 21, asks NVE President Robert Occhifinto to disclose information on its marketing practices and AEs related to sale of Yellow Jackets. Committee also recently expanded its inquiry to include PediaLean children's weight-loss supplement (1"The Tan Sheet" April 14, 2003, p. 4). Yellow Jackets and NVE were the subject of an FDA investigation and concurrent Senate subcommittee hearing in October 2002 (2"The Tan Sheet" Oct. 14, 2002, p. 6). Firm has until May 5 to respond...

Hill expands ephedra investigation

Former Yellow Jackets manufacturer NVE Pharmaceuticals is latest firm to receive House Energy & Commerce Committee letter as part of its ongoing ephedra investigation. Correspondence, sent April 21, asks NVE President Robert Occhifinto to disclose information on its marketing practices and AEs related to sale of Yellow Jackets. Committee also recently expanded its inquiry to include PediaLean children's weight-loss supplement (1"The Tan Sheet" April 14, 2003, p. 4). Yellow Jackets and NVE were the subject of an FDA investigation and concurrent Senate subcommittee hearing in October 2002 (2"The Tan Sheet" Oct. 14, 2002, p. 6). Firm has until May 5 to respond...

Related Content

Topics

UsernamePublicRestriction

Register

LL1129367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel